Karen Flynn is VP at WEST PHARMACEUTICAL SERVICES INC (WST). They have made 10 open-market trades across 4 companies since 2013, most recently 2026-06-15.
CIK 0001553599
1 open-market purchase totalling $5K since 2016, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WST | 23,692 | $9.1M |
| CTLT | 24,339 | $1.5M |
| SHC | 54,191 | $970K |
| QTRX | 57,212 | $164K |
| STVN | 5,757 | $109K |
| REPH | 39,283 | $82K |
| Total | $12.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-26 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STVN | SELL | 2026-06-15 | 2026-06-26 | $17.09 | $26K | +9.8% | +9.9% | +18.7% |
| CTLT | SELL | 2022-01-10 | 2022-01-11 | $116.64 | $577K | -11.5% | -13.6% | -8.7% |
| CTLT | SELL | 2021-01-11 | 2021-01-11 | $112.24 | $433K | +1.2% | +3.3% | -5.2% |
| CTLT | SELL · 10b5-1 | 2021-01-04 | 2021-01-05 | $104.42 | $10K | +11.3% | +9.3% | +1.9% |
| WST | SELL | 2018-08-07 | 2018-08-09 | $116.23 | $4.8M | +1.3% | +2.3% | -2.9% |
| REPH | BUY | 2016-12-16 | 2016-12-19 | $6.71 | $5K | +10.0% | +0.0% | +8.7% |
| WST | SELL | 2016-09-06 | 2016-09-07 | $83.28 | $2.4M | -2.1% | -9.2% | +0.4% |
| WST | SELL | 2015-11-10 | 2015-11-12 | $63.03 | $1.1M | -5.9% | -2.8% | -6.1% |
| WST | SELL | 2015-05-22 | 2015-05-26 | $55.24 | $171K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2015-05-18 | 2015-05-19 | $55.00 | $105K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2013-11-19 | 2013-11-19 | $47.75 | $263K | -5.9% | -2.8% | -2.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.